INTZ vs JAZZ · rev $2.3M vs P/E 1988, rev $2.28B
Intrusion Inc (INTZ) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Intrusion Inc (INTZ) is a software - infrastructure company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported INTZ revenue for 2026-06-30 was $2.3M. Net income was -$6.2M. INTZ currently screens at market cap $15.7M.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
INTZ currently screens at market cap $15.7M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the INTZ and JAZZ stock pages for the full models.
Not investment advice.